CMMB
Chemomab Therapeutics Ltd DRC
NASDAQ: CMMB · HEALTHCARE · BIOTECHNOLOGY
$1.47
+0.68% today
Updated 2026-04-30
Market cap
$11.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Chemomab Therapeutics Ltd DRC (CMMB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.38M | $-3.74M | $-8.58M | $-14.18M | $-16.51M | $-12.80M | $-12.38M | $-20.29M | $-23.55M | $-15.46M | $-11.22M |
| Capital expenditures | $87244.00 | $76058.00 | $34266.00 | $212303.00 | $95307.00 | $34234.00 | $239166.00 | $67732.00 | $2991.00 | $4.00 | $3026.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $125000.00 | $135000.00 | $130000.00 | $2.02M | $3.21M | $1.49M | $617000.00 | $623000.00 |
| Free cash flow | $-7.47M | $-3.81M | $-8.62M | $-14.39M | $-16.61M | $-12.84M | $-12.62M | $-20.36M | $-23.55M | $-15.46M | $-11.22M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |